Neutralizing Antibodies to SARS-CoV-2: An Important Mechanism of Immunity

The global COVID-19 pandemic has put the entire scientific and medical community to test with the urgent need to understand this novel virus (SARS-CoV-2) and the new disease (COVID-19).^1,2While the diagnostic industry has responded to the call in a record speed and gained substantial information, an emerging focus is to understand whether patients recovered from COVID-19 will develop protection or immunity.^3,4 Knowledge about acquired immunity to COVID-19 not only provides valuable insights for the development of vaccines and therapeutics but also enable the implementation of suitable policies and strategies for effective pandemic control.^5,6

Click here to read more about how neutralizing antibodies are an important mechanism to immunity for SARS-CoV-2.

References

1. Coronavirus disease (COVID-19) pandemic – WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

2. Coronavirus (COVID-19) – CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html

3. Interpreting Diagnostic Tests for SARS-CoV-2, N Sethuraman, et al, JAMA Published online May 6, 2020, DOI: 10.1001/jama.2020.8259

4. Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection? J Gil Melgaçoa, et al, Cellular Immunology 353 (2020) 104114, https://doi.org/10.1016/j.cellimm.2020.104114

5. “Immunity passports” in the context of COVID-19, Scientific Brief, https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19

6. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines, C Manners, et al, Cureus 12(6), 2020: e8399. DOI 10.7759/cureus.8399